Radiopharmaceuticals

Award Notice Posted

Solicitation number
VA52815Q0387
Agency
Awarded
to Pharmalogic Syracuse, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
VA528-16-D-0006 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS



General Information

Document Type: Combined Solicitation/Synopsis

Solicitation Number: VA528-15-Q-0387

Posted Date: 09/14/2015

Current Response Date: 09/21/2015

NAICS Code: 325412

Contracting Office Address

VISN 2 NCO (2-90)

Department of Veterans Affairs

1304 Buckley Road, Suite C104

Syracuse, NY 13212

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued.



This solicitation is a request for quotations (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 005-84/09-03-2015.



The associated North American Industrial Classification System (NAICS) code for this procurement is 325412, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 500 employees.



The Syracuse VA Medical Center is seeking to purchase radiopharmaceuticals.



All interested companies shall provide quotes for the following:



Supplies



Base Year (December, 1 2015 through November, 30 2016)



CLIN Radiopharmaceutical Unit of Measure Quantity SIZE PRICE FOR EACH mCi or Bulk TOTAL PRICE Number of Minutes Needed to Prepare Product at Radiopharmacy NDC OF OFFERED PRODUCT

1 Tc99m Myoview Unit dose 200 10mCi

2 Tc99mMyoview Unit dose 100 20mCi

3 Tc99m Myoview Unit dose 100 28mCi

4 Tc99m Myoview Unit dose 200 30mCi

5 Tc99m Ceretec (brain imaging) Unit dose 3 20mCi

6 Tc99m HMPAO WBC Unit dose 10 20mCi



7 Tc99m DTPA Unit dose 50 30mCi

8 Tc99m Hepatolite Unit dose 50 7mCi

9 Tc99m MAA Unit dose 50 10mCi

10 Tc99m MAG3 Unit dose 49 10mCi

11 Tc99m MDP Unit dose 300 25mCi

12 Tc99m Neurolite Unit dose 25mCi

13 Tc99m Sulfur Colloid Unit dose 25 1mCi

14 Tc99m Sulfur Colloid Unit dose 3 7mCi

15 Tc99m Sulfur colloid filtered Unit dose 5 1mCi

16 Tc99m Choletec Unit dose 25 10mCi

17 Tc99m (pertechnetate) Unit dose 20 5mCi

18 Tc99m (pertechnetate) Unit dose 9 10mCi

19 Tc99m (pertechnetate) Unit dose 10 28mCi

20 Tc99m (pertechnetate) Unit dose 10 30mCi

21 Tc99m (pertechnetate) Bulk 224 300mCi - bulk

22 Tl-201 Unit dose 10 4mCi

23 *I-131 NaI caps(therapeutic) capsule 60mCi

24 *I-131 NaI caps (therapeutic) capsule 3 100mCi



25 *I-131 NaI caps (therapeutic) capsule 1 125mCi



26 *I-131 NaI caps (therapeutic) capsule 1 150mCi



27 *I-131 NaI caps (therapeutic) capsule 175mCi



28 *I-131 NaI caps (therapeutic) capsule 1 200mCi

29 *I-131 NaI caps (diagnostic) capsule 2 2mCi

30 *I-131 NaI caps (diagnostic) capsule 2 3mCi



31 *I-131 NaI caps (diagnostic) capsule 2 4mCi



32 *I-131 NaI caps (diagnostic) capsule 2 5mCi



33 *I-131 NaI caps (diagnostic) capsule 2 10uCi

34 In111 WBC Unit dose 15 500uCi

35 In111 Octreoscan Unit dose 15 6mCi

36 Ga-67 Unit dose 3 6mCi

37 Ultra-tag kits kit 2 box of 5

38 CCK (Kinevac) injection vial 20 1.4ugm/kg

39 Pyrophosphate kits kit 5 kit

40 Cold kit MAA box 10 5 kits per box

41 Cold kit D.T.P.A kit 10 kit

42 Cold kit PYP kit 10 kit

43 Cold kit Mebrofenin kit 10 kit

44 meter calibrations each 4 yearly

45 Emergency order fee, to include Pharmacist preparation & delivery Delivery Approximately 2/week

(ESTIMATE 100 DELIVERIES ANNUALLY) ORDER

(ESTIMATE 156 DELIVERIES ANNUALLY)

TOTAL Base Year VALUE:



Option Year (December 1, 2016 through November 30, 2017)



CLIN Radiopharmaceutical Unit of Measure Quantity SIZE PRICE FOR EACH mCi or Bulk TOTAL PRICE Number of Minutes Needed to Prepare Product at Radiopharmacy NDC OF OFFERED PRODUCT

46 Tc99m Myoview Unit dose 200 10mCi

47 Tc99mMyoview Unit dose 100 20mCi

48 Tc99m Myoview Unit dose 100 28mCi

49 Tc99m Myoview Unit dose 200 30mCi

50 Tc99m Ceretec (brain imaging) Unit dose 3 20mCi

51 Tc99m HMPAO WBC Unit dose 10 20mCi



52 Tc99m DTPA Unit dose 50 30mCi

53 Tc99m Hepatolite Unit dose 50 7mCi

54 Tc99m MAA Unit dose 50 10mCi

55 Tc99m MAG3 Unit dose 49 10mCi

56 Tc99m MDP Unit dose 300 25mCi

57 Tc99m Neurolite Unit dose 25mCi

58 Tc99m Sulfur Colloid Unit dose 25 1mCi

59 Tc99m Sulfur Colloid Unit dose 3 7mCi

60 Tc99m Sulfur colloid filtered Unit dose 5 1mCi

61 Tc99m Choletec Unit dose 25 10mCi

62 Tc99m (pertechnetate) Unit dose 20 5mCi

63 Tc99m (pertechnetate) Unit dose 9 10mCi

64 Tc99m (pertechnetate) Unit dose 10 28mCi

65 Tc99m (pertechnetate) Unit dose 10 30mCi

66 Tc99m (pertechnetate) Bulk 224 300mCi - bulk

67 Tl-201 Unit dose 10 4mCi

68 *I-131 NaI caps(therapeutic) capsule 60mCi

69 *I-131 NaI caps (therapeutic) capsule 3 100mCi



70 *I-131 NaI caps (therapeutic) capsule 1 125mCi



71 *I-131 NaI caps (therapeutic) capsule 1 150mCi



72 *I-131 NaI caps (therapeutic) capsule 175mCi



73 *I-131 NaI caps (therapeutic) capsule 1 200mCi

74 *I-131 NaI caps (diagnostic) capsule 2 2mCi

75 *I-131 NaI caps (diagnostic) capsule 2 3mCi



76 *I-131 NaI caps (diagnostic) capsule 2 4mCi



77 *I-131 NaI caps (diagnostic) capsule 2 5mCi



78 *I-131 NaI caps (diagnostic) capsule 2 10uCi

79 In111 WBC Unit dose 15 500uCi

80 In111 Octreoscan Unit dose 15 6mCi

81 Ga-67 Unit dose 3 6mCi

82 Ultra-tag kits kit 2 box of 5

83 CCK (Kinevac) injection vial 20 1.4ugm/kg

84 Pyrophosphate kits kit 5 kit

85 Cold kit MAA box 10 5 kits per box

86 Cold kit D.T.P.A kit 10 kit

87 Cold kit PYP kit 10 kit

88 Cold kit Mebrofenin kit 10 kit

89 meter calibrations each 4 yearly

90 Emergency order fee, to include Pharmacist preparation & delivery Delivery Approximately 2/week

(ESTIMATE 100 DELIVERIES ANNUALLY) ORDER

(ESTIMATE 156 DELIVERIES ANNUALLY)

TOTAL Option Year VALUE:



Total Base plus 1 option years:



Services

See statement of work attached.



The delivery/task order period of performance is 12/01/2015 - 11/30/2017.



Delivery shall be provided starting on 12/01/2015. The department will call in the order on an as-needed basis. The contractor shall deliver ordered items as needed to the Hot Lab of the Syracuse VA Medical Center at 800 Irving Avenue, Syracuse, NY 13210.

Place of Performance

Address: Department of Veterans Affairs

800 Irving Avenue

Syracuse, NY 13210

Country: UNITED STATES



The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.



The following solicitation provisions apply to this acquisition:

1. FAR 52.212-1, "Instructions to Offerors-Commercial Items"

Vendor must be registered with the sam.gov to further qualify for this contract.



The offeror's quote shall, at a minimum, address each of the factors and additional documents listed in this RFP.



During evaluations of each quote, the Government will assess each area of the Technical Quote to ensure the offeror meets or exceeds the standards of the contract. The Government will evaluate the technical quote based on the evaluation criteria described in the Evaluation Section below, as well as those requirements listed in the SOW. The Government will infer from the offeror's responses to these specified evaluation criteria the offeror's capability to perform to the requirements of the entire SOW.

2. FAR 52.212-2, "Evaluation-Commercial Items" (Oct 2014)

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

Factor 1: Technical Approach/Capability: Contractor is to provide clear evidence of the overall technical approach; proposed methodology; and a demonstrated understanding of the scope of work and the requirements

Factor 2: Past Performance

Factor 3: Price



(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).



(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.



3. FAR 52.212-3, "Offerors Representations and Certifications-Commercial Items"

Offerors must complete annual representations and certifications on-line at http://orca.bpn.gov in accordance with FAR 52.212-3, "Offerors Representations and Certifications-Commercial Items." If paragraph (j) of the provision is applicable, a written submission is required.



The following contract clauses apply to this acquisition:

FAR 52.212-4, "Contract Terms and Conditions-Commercial Items" (July 2013)

FAR 52.212-5, "Contract Terms and Conditions Required to Implement Statutes or Executive Orders" (August 2013). The following subparagraphs of FAR 52.212-5 are applicable: (b), 1, 4, 6, 7 14, 23, 26, 27, 28, 29, 30, 31,32, 33, 38, 39, 41, 42, and 48

52.204-7 System for Award Management

52.204-13 System for Award Management Maintenance

52.209-2 Prohibition on Contracting with Inverted Domestic Corporations-Representation

52.209-5, Representation By Corporations Regarding An Unpaid Tax Liability Or A Felony Conviction Under Any Federal Law

52.209-10 Prohibition on Contracting with Inverted Domestic Corporations

52.216-22, Indefinite Quantity

52.217-5, Evaluation of Options

52.217-6, Option for Increased Quantity

52.217-9, Option to Extend the Term of the Contract

52.222-22 Previous Contracts Compliance Report

52.222-25 Affirmative Action Compliance

52.222-36 Affirmative Action for Workers with Disabilities

52.222-50 Combatting Trafficking in Persons

52.223-3, Hazardous Material Identification and Material Safety Data - Alternate I (Jan 1997).

52.225-5 Trade Agreements

52.225-25 Prohibition on Contracting with Entities Engaging in Certain Activities or Transactions Relating to Iran--Representation and Certifications.

52.232-18, Availability of Funds

52.232-33 Payment by Electronic Funds Transfer-System for Award Management

52.232-39 Unenforceability of Unauthorized Obligations

52.233-3 Protest After Award

52.233-4 Applicable Law for Breach of Contract Claim

52.247-34 FOB Destination

852.216-70, Estimated quantities (Apr 1984)

852.232-72, Electronic submission of payment requests (Nov 2012)

852.246-70, Guarantee

852.246-71, Inspection (Jan 2008)

852.270-1, Representatives of Contracting Officers



Quote packages must include the following or responses will be considered non-responsive:

1. Spec sheets, product literature, brochures, etc that fully describe the products being offered

2. Warranty Provisions

3. Pricing

4. Completed Reps and Certs if offeror does not list the NAICS code on their annual ORCA submission.

5. Signed Standard Form 1449, and acknowledgment of all amendments.

6. VA Approved Business Associate Agreement, if any

7. Vendor must include a copy of their Nuclear Pharmacy License

8. Vendor must show ability to deliver products Monday through Friday by 7:00 AM. Vendor must provide a MapQuest illustration showing their ability to deliver.

Vendor must provide an emergency plan procedure for deliveries in inclement weather.



All quote packages shall be emailed to Allison.Dubin2@va.gov.



This is an open-market combined synopsis/solicitation for radiopharmaceuticals as defined herein. The government intends to award an IDIQ contract as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows:

"The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition."

OR

"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"

Quoter shall list exception(s) and rationale for the exception(s).



Submission shall be received not later than Monday September 21st at 5:00 pm.. Quotes and supporting documentation must be emailed to Allison Dubin at Allison Dubin2@va.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).



Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Contracting Officer, Allison Dubin, Allison.Dubin2@va.gov.

Point of Contact

Allison Dubin, Allison.Dubin2@va.gov

Files

File Type Posted
VA528-16-D-0006-000.docx DOCX document
VA528-15-Q-0387-001.docx DOCX document
VA528-15-Q-0387-000.docx DOCX document

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors